Concepedia

Publication | Open Access

A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders

DOIFull Paper Access

112

Citations

16

References

2011

Year

David A. Geier, Janet K. Kern, Georgia Davis, Paul King, James B. Adams, John L. Young, Mark R. Geier
Medical Science Monitor

Abstract

L-carnitine therapy (50 mg/kilogram-bodyweight/day) administered for 3-months significantly improved several clinical measurements of ASD severity, but subsequent studies are recommended.

References

YearCitations

Page 1